Andorra Health Watch
SEE OTHER BRANDS

Exploring the health and wellness news of Andorra

Therapeutics: Misonix Inks Spain Distribution Deal

September 10, 2010 (FinancialWire) (Go to http://www.financialwire.net/?s=ftrdnwswnd for all of today’s featured news.) — Misonix, Inc. (NASDAQ: MSON), a developer of ultrasonic medical device technology, said it has entered into a new, three year, exclusive distribution agreement with Spain-based Dismeval, s.l. under which Dismeval will sell and distribute Misonix’s SonaStar Ultrasonic Surgical Aspirator and the BoneScalpel Ultrasonic Bone Cutter throughout Spain, Morocco, and Andorra.

According to Misonix, the agreement includes annual minimum purchase requirements.  

Dismeval specializes in introducing medical products to the Spanish and Moroccan markets, with a clinical focus on neuro, spine, ENT, and maxillo-facial surgery.

The SonaStar is used by neuro and general surgeons for removal of both hard and soft tumors while sparing most vessels. In addition, OsteoSculpt bone sculpting technology can be employed with the SonaStar to remove osseous structures, thus providing access to the surgical site.

The BoneScalpel is a tissue specific osteotomy device capable of making precise cuts through bone and hard tissue while largely preserving delicate soft tissue structures.

New York-based Misonix designs, develops, manufactures and markets therapeutic ultrasonic medical devices and laboratory equipment.  

Real-time, streaming research for companies and funds mentioned in FinancialWire(tm) news is available via the Investrend Research Syndicate (at http://investrend.stocksmart.com/ss/html/hpcompany.html). Current valuation analysis research for companies and funds mentioned in FinancialWire(tm) news is available via the Investrend Research Syndicate (at http://www.valuengine.com/rep/searchsrep?pid=42&srchfor=).

FinancialWire(tm) is committed to serving the financial community through true journalism and providing relevant resources to investors. Standards-based, independent equity research on numerous public other companies is available through the Investrend Research Syndicate (http://www.investrend.com/reports) written by FIRST Research Consortium (http://www.investrend.com/FIRST) member-providers. Free annual reports and company filings for companies mentioned in the news are available through the Investrend Information Syndicate (at http://investrend.ar.wilink.com/?level=279). FinancialWire(tm), in cooperation with the Investrend Broadcast Syndicate, also provides complete, daily conference call and webcast schedules as a service to shareholders and investors via the FirstAlert(tm) Network’s “FirstAlert(tm) Daily” (at http://www.financialwire.net/news-alerts/).

FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation from subject entities, companies, equities, or representatives thereof, for its news, opinions or distributions. Further disclosure is posted at the FinancialWire(tm) website (at http://www.financialwire.net/disclosures.php and http://www.financialwire.net/2010/04/23/safe-harbor/). Additional resources for investors are also accessible via the FinancialWire(tm) website (at http://www.financialwire.net/2010/04/23/investor-resources/). Contact FinancialWire(tm) directly via inquiries@financialwire.net.

Copyright © MMX, FinancialWire(tm); All rights reserved.

[hlmsmlh] [hlthcrdp] [nwdlsldw] [ntrntnlcmpnsbsnss] [erpnpre] [ftrdnwswnd] [thrptcsct]

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service